August 28, 2018

The Coming Age of Strategic Innovation in Medical Device

Efficient and effective engineering and new device development have always been central to the success of medical device companies.  Under the traditional, Fee-For-Service reimbursement landscape, companies could identify costly or marginally effective procedures and develop products that improved patient outcomes while lowering the current cost of care.  As medical device companies evolved, many developed a particular rhythm to the development and commercialization process.  In the past, I’ve worked with device companies that actually held off […]
August 9, 2018

Leveraging a Culture of Innovation in Device Development

While innovation may simply be the next buzz word resonating throughout industry, it’s a competitive imperative in medical device.  Yet, identifying the causal inputs that drive sustainable, efficient innovation remain elusive for many firms.  This need not be the case.  Setting the stage for innovation, and developing a culture that supports and nurtures adaptive thinking (solving novel, heretofore unforeseen challenges), are actually grounded in science. Values-Driven Culture Research from the field of positive psychology has […]
April 12, 2018
Internal Drug Delivery Device

De-Risking the Development of Drug/Device Combination Products

Navigating the Critical Path with Combination Products A market research study, published earlier this week by Market.Biz, illustrates the promise of what is perhaps the most dynamic technology segment emerging in healthcare; combination products. The research pegged the value of the combination products market at $64.7 billion in 2017, and projects a CAGR (current annual growth rate) of 13.8% through 2023, escalating the market value to a staggering $94.5 billion by that time. One of […]
March 29, 2018

Strategic Risk Management in Medical Device Development and Innovation

Employing Clinical Pathway Impact Analysis™ to drive efficacy at launch. While large medical device corporations have long looked to startups for new technologies and devices, there are additional, innovative benefits woven into the fabric of these nimble firms. Startups that survive long enough to deliver commercial assets must first survive a form of natural selection. A similar process can benefit any new device development project. At each stage of organizational progression, from seed funding to […]
Schedule a Conversation
Contact Us